Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contrast Agents for Enhanced Bioimaging: A Comprehensive Review.

Chembiochem : a European journal of chemical biology·2026
Same author

Impact of hyperglycemia on glioblastoma cell proliferation and the therapeutic potential of green-synthesized cerium oxide nanoparticles.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Inorganic Nanoparticles Containing Plant-Derived Compounds for Kidney Treatment.

Bioinorganic chemistry and applications·2025
Same author

Perspectives and state-of-the-art use of metal-derived, porous nanomaterials and metallo-drugs for biomedical applications.

3 Biotech·2025
Same author

Advancements in nanotheranostics for glioma therapy.

Naunyn-Schmiedeberg's archives of pharmacology·2024
Same author

Multifunctional gold nanoparticles for cancer theranostics.

3 Biotech·2024

Related Experiment Video

Updated: Jul 12, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K

Liposomes for Cancer Theranostics.

Donald A Fernandes1

  • 1Independent Researcher, Toronto, ON, Canada.

Pharmaceutics
|October 28, 2023
PubMed
Summary
This summary is machine-generated.

Nanotechnology offers advanced liposomes for targeted cancer therapy and imaging. These nanoparticles improve drug delivery, overcome resistance, and enable treatment monitoring for better cancer care.

Keywords:
image-guided therapyimagingnanoparticlestheranosticstherapy

More Related Videos

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

7.7K

Related Experiment Videos

Last Updated: Jul 12, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
09:00

Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors

Published on: August 18, 2016

7.7K

Area of Science:

  • Oncology
  • Nanomedicine
  • Biotechnology

Background:

  • Cancer remains a leading cause of death despite advancements in treatment.
  • Conventional therapies face limitations like poor drug specificity, resistance, and side effects.
  • Nanotechnology provides novel strategies for targeted cancer cell destruction.

Purpose of the Study:

  • To review various liposomal nanoparticles for cancer theranostics.
  • To discuss applications of liposomes in drug delivery and imaging.
  • To explore different cancer treatment and imaging modalities using liposomes.

Main Methods:

  • Review of scientific literature on liposomes in cancer therapy.
  • Analysis of nanoparticle characteristics for drug delivery and targeting.
  • Examination of imaging agents and therapeutic modalities compatible with liposomes.

Main Results:

  • Liposomes effectively deliver therapeutic agents and targeting moieties to cancer cells.
  • Nanoparticles enable enhanced drug specificity and reduced toxicity.
  • Integrated imaging agents allow for real-time treatment monitoring.
  • Various liposomal formulations support diverse treatments like photothermal and photodynamic therapy.

Conclusions:

  • Liposomes are versatile nanocarriers for advanced cancer theranostics.
  • Nanotechnology-based liposomes show significant potential to improve cancer treatment outcomes.
  • Further research into liposomal applications can overcome current therapeutic challenges.